<?xml version="1.0" encoding="UTF-8"?>
<p id="Par110">Patients are not allowed to receive cytotoxic, immunotherapeutic or molecularly targeted agents within a time period commencing 2 weeks prior to initiation of radiotherapy until 6 weeks after completion of therapy. Patients on conventional hormone therapy (i.e. anti-estrogen or anti-testosterone therapy) may continue these medications.</p>
